Reversal of Neuronal Tau Pathology via Adiponectin Receptor Activation
Author Information
Author(s): McGregor Eric R., Lasky Danny J., Rippentrop Olivia J., Clark Josef P., Wright Samantha, Jones Mathew V., Anderson Rozalyn M.
Primary Institution: University of Wisconsin-Madison
Hypothesis
Can adiponectin receptor activation reverse tau pathology in neurons?
Conclusion
Adiponectin receptor activation can clear neurofibrillary tangles and restore neuronal function in tauopathy-prone neurons.
Supporting Evidence
- AdipoRon treatment significantly reduced levels of phosphorylated tau.
- AMPK activation was shown to be necessary for the clearance of tau pathology.
- Neuronal function, including dendritic complexity and electrophysiological properties, was restored with AdipoRon treatment.
Takeaway
This study shows that a special treatment can help fix brain cells that are sick because of a problem called tauopathy, which is related to diseases like Alzheimer's.
Methodology
The study used primary neurons from tauopathy mouse models and treated them with AdipoRon to assess changes in tau pathology and neuronal function.
Limitations
The study was conducted in vitro and may not fully represent in vivo conditions.
Participant Demographics
Primary neurons from P0 hTau P301S and APP/PS1 mice were used.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website